Abbonarsi

Novel risk stratification for recurrence after endoscopic resection of advanced colorectal adenoma - 23/02/15

Doi : 10.1016/j.gie.2014.09.064 
Ji Yeon Seo, MD 1, Jaeyoung Chun, MD 1, Changhyun Lee, MD 2, Kyoung Sup Hong, MD, PhD 1, Jong Pil Im, MD, PhD 1, Sang Gyun Kim, MD, PhD 1, Hyun Chae Jung, MD, PhD 1, Joo Sung Kim, MD, PhD 1,
1 Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea 
2 Department of Internal Medicine and Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea 

Reprint requests: Joo Sung Kim, MD, PhD, Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, South Korea.

Abstract

Background

Advanced colorectal adenoma (ACA) refers to adenomas with the following predictive characteristics: ≥1 cm in diameter, and/or villous component, and/or high-grade dysplasia. ACA has high risk of transforming to colorectal cancer, and the recurrence rate is relatively high.

Objective

To assess the outcomes of patients with ACA undergoing endoscopic resection and to identify risk factors for local recurrence and development of metachronous advanced neoplasm.

Design

Retrospective cohort study.

Setting

Tertiary care medical center.

Patients

From 2005 to 2011, the records of 3625 patients who underwent colonoscopic polypectomy at Seoul National University Hospital were retrospectively reviewed. Patients with synchronous colorectal cancers, inflammatory bowel disease, previous colorectal resection, loss to follow-up, and incomplete resection were excluded.

Intervention

Endoscopic resection for ACA.

Main Outcome Measurements

Local recurrence and metachronous advanced neoplasm.

Results

The study included 917 patients with 1206 ACAs. The median duration of follow-up was 28.5 months (interquartile range, 12.8-51.7). Independent risk factors for local recurrence included ACA with 2 or more predictive characteristics (adjusted hazard ratio [HR], 2.46; 95% confidence interval [CI], 1.11-5.48; P = .027) and piecemeal resection (adjusted HR, 6.96; 95% CI, 1.58-30.71; P = .010). Independent risk factors for metachronous advanced neoplasm were male gender (adjusted HR, 1.65; 95% CI, 1.02-2.65; P = .041), ≥3 adenomas (adjusted HR, 2.56; 95% CI, 1.72-3.82; P < .001), and ≥3 ACAs (adjusted HR, 1.44; 95% CI, 1.01-2.06; P = .045).

Limitations

Retrospective design.

Conclusion

ACAs with 2 or more predictive characteristics recurred locally at a higher rate than ACAs with 1 predictive characteristic. These results suggest that patients who are found to have ACAs with 2 or more predictive factors at index colonoscopy are at higher risk for local recurrence, and follow-up colonoscopy should be performed sooner.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : ACA, CI, CRC, ESD, HR, IQR, SNUH


Mappa


 DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.
 If you would like to chat with an author of this article, you may contact Dr Kim at jooskim@snu.ac.kr.


© 2015  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 81 - N° 3

P. 655-664 - marzo 2015 Ritorno al numero
Articolo precedente Articolo precedente
  • Identification of physicians with unusual performance in screening colonoscopy databases: a Bayesian approach
  • Christian Stock, Lorenz Uhlmann, Michael Hoffmeister, Gunter Laux, Meinhard Kieser, Hermann Brenner
| Articolo seguente Articolo seguente
  • Predicting inadequate bowel preparation for colonoscopy in participants receiving split-dose bowel preparation: development and validation of a prediction score
  • Vincent K. Dik, Leon M.G. Moons, Melek Hüyük, Peter van der Schaar, Wouter H. de Vos tot Nederveen Cappel, Pieter C.J. ter Borg, Maarten A.C. Meijssen, Rob J.T.H. Ouwendijk, Doris M. Le Fèvre, Merijn Stouten, Onno van der Galiën, Theo J. Hiemstra, Jan F. Monkelbaan, Martijn G.H. van Oijen, Peter D. Siersema

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.